Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX $453.74)
- $453.74 P/E (TTM): 29.51X Cap: $115.26B
- View VRTX Profile
- View Questions on VRTX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $468.55)
- $468.55 P/E (TTM): 60.74X Cap: $166.39B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $453.74)
- $453.74 P/E (TTM): 29.51X Cap: $115.26B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $211.12)
- $211.12 P/E (TTM): 86.83X Cap: $373.42B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $239.24)
- $239.24 P/E (TTM): 21.34X Cap: $576.23B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $897.00)
- $897.00 P/E (TTM): 39.68X Cap: $847.50B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $118.93)
- $118.93 P/E (TTM): 15.89X Cap: $294.04B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $165.26)
- $165.26 P/E (TTM): 20.63X Cap: $7.99B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $573.29)
- $573.29 P/E (TTM): 44.23X Cap: $45.58B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $63.29)
- $63.29 P/E (TTM): 24.85X Cap: $7.49B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $92.26)
- $92.26 P/E (TTM): 14.11X Cap: $18.36B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.25)
- $24.25 P/E (TTM): 13.8X Cap: $2.96B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $27.92)
- $27.92 P/E (TTM): 361.42X Cap: $233.46B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Vertex Pharmaceuticals Incorporated (VRTX $453.74)
- $453.74 P/E (TTM): 29.51X Cap: $115.26B
- View VRTX Profile
- View Questions on VRTX
CRISPR Therapeutics AG (CRSP $47.55)
- $47.55 Cap: $4.56B
- View CRSP Profile
- View Questions on CRSP

Q: What is your opinion regarding the future of CRSP? Buy, sell, hold?

Read Answer Asked by Judith on May 21, 2025

Vertex Pharmaceuticals Incorporated (VRTX $453.74)
- $453.74 P/E (TTM): 29.51X Cap: $115.26B
- View VRTX Profile
- View Questions on VRTX

Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.

Read Answer Asked by Marco on February 14, 2025